the women's cancer centre limited
the women's cancer centre limited Company Information
Company Number
05648560
Website
-Registered Address
143 harley street, ground floor, london, W1G 6BH
Industry
General medical practice activities
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
carecapital ltd 100%
the women's cancer centre limited Estimated Valuation
Pomanda estimates the enterprise value of THE WOMEN'S CANCER CENTRE LIMITED at £0 based on a Turnover of £0 and 0.54x industry multiple (adjusted for size and gross margin).
the women's cancer centre limited Estimated Valuation
Pomanda estimates the enterprise value of THE WOMEN'S CANCER CENTRE LIMITED at £0 based on an EBITDA of £0 and a 4.52x industry multiple (adjusted for size and gross margin).
the women's cancer centre limited Estimated Valuation
Pomanda estimates the enterprise value of THE WOMEN'S CANCER CENTRE LIMITED at £0 based on Net Assets of £0 and 2.93x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Women's Cancer Centre Limited Overview
The Women's Cancer Centre Limited is a live company located in london, W1G 6BH with a Companies House number of 05648560. It operates in the general medical practice activities sector, SIC Code 86210. Founded in December 2005, it's largest shareholder is carecapital ltd with a 100% stake. The Women's Cancer Centre Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Women's Cancer Centre Limited Health Check
There is insufficient data available to calculate a health check for The Women'S Cancer Centre Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- The Women's Cancer Centre Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (17)
- - The Women's Cancer Centre Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - The Women's Cancer Centre Limited
- - Industry AVG
THE WOMEN'S CANCER CENTRE LIMITED financials
The Women'S Cancer Centre Limited's latest turnover from December 2022 is 0 and the company has net assets of 0. According to their latest financial statements, The Women'S Cancer Centre Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,750 | |
| Other Income Or Grants | 0 | 0 | 0 | |||||||||||
| Cost Of Sales | 0 | 0 | 0 | |||||||||||
| Gross Profit | 0 | 0 | 0 | |||||||||||
| Admin Expenses | 0 | 0 | 0 | |||||||||||
| Operating Profit | 0 | 0 | 0 | -7,779 | -63,857 | -40,097 | -923,800 | -448,742 | -1,080,704 | -39,533 | -41,522 | 251,077 | -321,861 | |
| Interest Payable | 0 | 0 | 0 | 346,443 | 320,100 | 330,296 | 107,808 | 202,198 | 169,427 | 179,650 | 180,909 | 191,088 | 191,707 | |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Pre-Tax Profit | 0 | 0 | -566 | -354,222 | -383,957 | -370,393 | -1,031,608 | -650,940 | -1,250,131 | -219,183 | -222,431 | 61,488 | -513,568 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Tax | 0 | 0 | -566 | -354,222 | -383,957 | -370,393 | -1,031,608 | -650,940 | -1,250,131 | -219,183 | -222,431 | 61,488 | -513,568 | |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Retained Profit | 0 | 0 | -566 | -354,222 | -383,957 | -370,393 | -1,031,608 | -650,940 | -1,250,131 | -219,183 | -222,431 | 61,488 | -513,568 | |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Number Of Employees | 1 | 1 | 2 | 2 | 1 | 2 | 1 | |||||||
| EBITDA* | 0 | 0 | 0 | -7,779 | -63,857 | -40,097 | -923,800 | -448,742 | -1,080,704 | -39,533 | -41,522 | 251,077 | -321,861 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 350,000 | 310,000 | 310,000 | 310,000 | 1,197,093 | 2,000,000 | 3,049,635 | 3,049,635 | 3,049,635 | 3,049,635 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 350,000 | 310,000 | 310,000 | 310,000 | 1,197,093 | 2,000,000 | 3,049,635 | 3,049,635 | 3,049,635 | 3,049,635 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,710 | 633 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,574 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 2,398 | 12,076 | 7,762 | 6,894 | 26,944 | 2,209 | 1,102 | 8,110 | 5,674 | 13,870 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 25,737 | 50,788 | 42,618 | 359 | 9 | 173 | 2,743 | 313 |
| misc current assets | 0 | 0 | 0 | 0 | 2,103 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 0 | 0 | 0 | 0 | 4,501 | 12,076 | 33,499 | 57,682 | 69,562 | 2,568 | 1,111 | 8,283 | 16,701 | 14,816 |
| total assets | 0 | 0 | 0 | 0 | 354,501 | 322,076 | 343,499 | 367,682 | 1,266,655 | 2,002,568 | 3,050,746 | 3,057,918 | 3,066,336 | 3,064,451 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 543,250 | 1,000,000 | 987,832 | 2,582,273 | 2,580,648 | 2,579,273 | 2,621,028 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,700,932 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 10,099 | 170 | 19 | 0 | 4,404 | 38,249 | 36,269 | 18,244 | 6,822 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 5,305,121 | 4,912,645 | 3,825,437 | 2,885,361 | 2,769,041 | 1,324,116 | 1,026,880 | 1,006,143 | 853,583 | 823,774 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 5,306 | 1,036 | 192,389 | 329,656 | 325,528 | 256,581 | 319,644 | 131,725 | 46,542 | 67,472 |
| total current liabilities | 0 | 0 | 0 | 0 | 5,310,427 | 4,923,780 | 4,561,246 | 4,215,036 | 4,082,401 | 4,167,374 | 3,965,421 | 3,753,410 | 3,539,397 | 3,599,000 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 5,310,427 | 4,923,780 | 4,561,246 | 4,215,036 | 4,082,401 | 4,167,374 | 3,965,421 | 3,753,410 | 3,539,397 | 3,599,000 |
| net assets | 0 | 0 | 0 | 0 | -4,955,926 | -4,601,704 | -4,217,747 | -3,847,354 | -2,815,746 | -2,164,806 | -914,675 | -695,492 | -473,061 | -534,549 |
| total shareholders funds | 0 | 0 | 0 | 0 | -4,955,926 | -4,601,704 | -4,217,747 | -3,847,354 | -2,815,746 | -2,164,806 | -914,675 | -695,492 | -473,061 | -534,549 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 0 | 0 | 0 | -7,779 | -63,857 | -40,097 | -923,800 | -448,742 | -1,080,704 | -39,533 | -41,522 | 251,077 | -321,861 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | -2,398 | -9,678 | 4,314 | 868 | -20,050 | 24,735 | 1,107 | -7,008 | -5,848 | -545 | 14,503 |
| Creditors | 0 | 0 | 0 | 0 | -10,099 | 9,929 | 151 | 19 | -4,404 | -33,845 | 1,980 | 18,025 | 11,422 | 6,822 |
| Accruals and Deferred Income | 0 | 0 | 0 | -5,306 | 4,270 | -191,353 | -137,267 | 4,128 | 68,947 | -63,063 | 187,919 | 85,183 | -20,930 | 67,472 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 0 | 0 | 0 | -3,930 | -249,595 | -178,081 | -899,603 | -408,934 | -1,178,719 | 157,374 | 67,534 | 242,114 | -262,070 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | -350,000 | 40,000 | 0 | 0 | -887,093 | -802,907 | -1,049,635 | 0 | 0 | 0 | 3,049,635 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2,700,932 | 2,700,932 |
| Group/Directors Accounts | 0 | 0 | 0 | -5,305,121 | 392,476 | 1,087,208 | 940,076 | 116,320 | 1,444,925 | 297,236 | 20,737 | 152,560 | 29,809 | 823,774 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | 0 | 0 | 0 | -346,443 | -320,100 | -330,296 | -107,808 | -202,198 | -169,427 | -179,650 | -180,909 | -191,088 | -191,707 | |
| cash flow from financing | 0 | 0 | 566 | 46,033 | 767,108 | 609,780 | 8,512 | 1,242,727 | 127,809 | -158,913 | -28,349 | -2,862,211 | 3,312,018 | |
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | -25,737 | -25,051 | 8,170 | 42,259 | 350 | -164 | -2,570 | 2,430 | 313 |
| overdraft | 0 | 0 | 0 | 0 | 0 | -543,250 | -456,750 | 12,168 | -1,594,441 | 1,625 | 1,375 | -41,755 | 2,621,028 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 517,513 | 431,699 | -3,998 | 1,636,700 | -1,275 | -1,539 | 39,185 | -2,618,598 | 313 |
the women's cancer centre limited Credit Report and Business Information
The Women's Cancer Centre Limited Competitor Analysis
Perform a competitor analysis for the women's cancer centre limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
the women's cancer centre limited Ownership
THE WOMEN'S CANCER CENTRE LIMITED group structure
The Women'S Cancer Centre Limited has no subsidiary companies.
Ultimate parent company
2 parents
THE WOMEN'S CANCER CENTRE LIMITED
05648560
the women's cancer centre limited directors
The Women'S Cancer Centre Limited currently has 2 directors. The longest serving directors include Dr Michael Sinclair (Jan 2013) and Mr Nicolas Serandour (Sep 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Michael Sinclair | 81 years | Jan 2013 | - | Director | |
| Mr Nicolas Serandour | England | 48 years | Sep 2018 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
0
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
the women's cancer centre limited company details
company number
05648560
Type
Private limited with Share Capital
industry
86210 - General medical practice activities
incorporation date
December 2005
age
19
accounts
Dormant
ultimate parent company
previous names
the women's cancer center limited (August 2013)
carecapital (folkestone) limited (June 2013)
incorporated
UK
address
143 harley street, ground floor, london, W1G 6BH
last accounts submitted
December 2022
the women's cancer centre limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to the women's cancer centre limited. Currently there are 1 open charges and 4 have been satisfied in the past.
the women's cancer centre limited Companies House Filings - See Documents
| date | description | view/download |
|---|
